BRIDGEBIO PHARMA INC

CUSIP: 10806XAB8 Class: NOTE 2.500% 3/1

Calamos Advisors LLC's Holding History (CIK: 0001316507)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 493,000 Value ($000) $931 Avg Close — Range —
Q3 2025
Shares 5,430,000 Value ($000) $7,621 Avg Close — Range —
Q2 2025
Shares 10,386,000 Value ($000) $12,992 Avg Close — Range —
Q1 2025
Shares 10,392,000 Value ($000) $11,875 Avg Close — Range —
Q4 2024
Shares 10,000,000 Value ($000) $10,502 Avg Close — Range —
Q3 2024
Shares 10,000,000 Value ($000) $10,305 Avg Close — Range —
Q2 2024
Shares 10,000,000 Value ($000) $10,124 Avg Close — Range —
Q1 2024
Shares 10,000,000 Value ($000) $10,768 Avg Close — Range —
Q4 2023
Shares 10,000,000 Value ($000) $12,087 Avg Close — Range —
Q3 2023
Shares 10,000,000 Value ($000) $9,774 Avg Close — Range —
Q2 2023
Shares 10,000,000 Value ($000) $7,815 Avg Close — Range —
Q1 2023
Shares 10,000,000 Value ($000) $7,444 Avg Close — Range —
Q4 2022
Shares 10,000,000 Value ($000) $4,591 Avg Close — Range —
Q3 2022
Shares 10,000,000 Value ($000) $5,931 Avg Close — Range —
Q2 2022
Shares 10,000,000 Value ($000) $5,477 Avg Close — Range —
Q1 2022
Shares 10,000,000 Value ($000) $5,936 Avg Close — Range —
Q4 2021
Shares 10,000,000 Value ($000) $7,372 Avg Close — Range —
Q3 2021
Shares 16,000,000 Value ($000) $22,119 Avg Close — Range —
Q2 2021
Shares 6,000,000 Value ($000) $9,853 Avg Close — Range —
Q1 2021
Shares 6,000,000 Value ($000) $9,930 Avg Close — Range —